关注
Cheong Siew Lee
Cheong Siew Lee
在 imu.edu.my 的电子邮件经过验证
标题
引用次数
引用次数
年份
The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches
SL Cheong, S Federico, G Venkatesan, AL Mandel, YM Shao, S Moro, ...
Medicinal Research Reviews 33 (2), 235-335, 2013
572013
The current status of pharmacotherapy for the treatment of Parkinson’s disease: Transition from single-target to multitarget therapy
SL Cheong, S Federico, G Spalluto, KN Klotz, G Pastorin
Drug discovery today 24 (9), 1769-1783, 2019
522019
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA3 …
SL Cheong, A Dolzhenko, S Kachler, S Paoletta, S Federico, B Cacciari, ...
Journal of Medicinal Chemistry 53 (8), 3361-3375, 2010
442010
Current progress in antimalarial pharmacotherapy and multi-target drug discovery
NS Tibon, CH Ng, SL Cheong
European journal of medicinal chemistry 188, 111983, 2020
432020
Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A2A Adenosine Receptor Antagonists with Improved Water …
S Federico, S Paoletta, SL Cheong, G Pastorin, B Cacciari, S Stragliotto, ...
Journal of medicinal chemistry 54 (3), 877-889, 2011
412011
Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment
YM Shao, X Ma, P Paira, A Tan, DR Herr, KL Lim, CH Ng, G Venkatesan, ...
PloS one 13 (1), e0188212, 2018
342018
Organoruthenium Antagonists of Human A3 Adenosine Receptors
P Paira, MJ Chow, G Venkatesan, VK Kosaraju, SL Cheong, KN Klotz, ...
Chemistry–A European Journal 19 (25), 8321-8330, 2013
182013
Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure-activity relationships
SL Cheong, G Venkatesan, P Paira, R Jothibasu, AL Mandel, S Federico, ...
International Journal of Medicinal Chemistry 2011, 2011
172011
Discovery of simplified N2-substituted pyrazolo [3, 4-d] pyrimidine derivatives as novel adenosine receptor antagonists: Efficient synthetic approaches, biological evaluations …
G Venkatesan, P Paira, SL Cheong, K Vamsikrishna, S Federico, KN Klotz, ...
Bioorganic & Medicinal Chemistry 22 (5), 1751-1765, 2014
162014
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists
SL Cheong, S Federico, G Venkatesan, P Paira, YM Shao, G Spalluto, ...
Bioorganic & medicinal chemistry letters 21 (10), 2898-2905, 2011
152011
Design, Synthesis and Characterisation of Novel Phenothiazine‐Based Triazolopyridine Derivatives: Evaluation of Anti‐Breast Cancer Activity on Human Breast Carcinoma
T Sachdeva, ML Low, CW Mai, SL Cheong, YK Liew, MD Milton
ChemistrySelect 4 (43), 12701-12707, 2019
142019
Does the combination of optimal substitutions at the C2-, N5-and N8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A3 …
SL Cheong, AV Dolzhenko, S Paoletta, EPR Lee, S Kachler, S Federico, ...
Bioorganic & medicinal chemistry 19 (20), 6120-6134, 2011
122011
A facile and novel synthesis of N2-, C6-substituted pyrazolo [3, 4-d] pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists
G Venkatesan, P Paira, SL Cheong, S Federico, KN Klotz, G Spalluto, ...
European Journal of Medicinal Chemistry 92, 784-798, 2015
92015
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
SL Cheong, JK Tiew, YH Fong, HW Leong, YM Chan, ZL Chan, ...
Pharmaceuticals 15 (12), 1560, 2022
62022
Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases
YC Chow, HC Yam, B Gunasekaran, WY Lai, WY Wo, T Agarwal, YY Ong, ...
Frontiers in Cellular and Infection Microbiology 12, 1456, 2022
42022
Inhibition of Porphyromonas gingivalis peptidyl arginine deiminase, a virulence factor, by antioxidant-rich Cratoxylum cochinchinense: In vitro and in silico evaluation
SA Tan, HC Yam, SL Cheong, YC Chow, CY Bok, JM Ho, PY Lee, ...
Saudi Journal of Biological Sciences 29 (4), 2573-2581, 2022
32022
Pharmacological relationships and ligand discovery of G protein-coupled receptors revealed by simultaneous ligand and receptor clustering
C Zhang, YM Shao, X Ma, SL Cheong, C Qin, L Tao, P Zhang, S Chen, ...
Journal of Molecular Graphics and Modelling 76, 136-142, 2017
12017
Novel Cu (II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains
WK Gan, HS Liew, LJW Pua, XY Ng, KW Fong, SL Cheong, YK Liew, ...
International Journal of Peptide Research and Therapeutics 28 (2), 60, 2022
2022
Design, synthesis and evaluation of new indolylpyrimidylpiperazines for gastrointestinal cancer therapy
A Tan, MV Babak, G Venkatesan, C Lim, KN Klotz, DR Herr, SL Cheong, ...
Molecules 24 (20), 3661, 2019
2019
A3 adenosine receptor ligands in the treatment of inflammation and cancer
SL Cheong, S Federico, A Tan Bon Wu, G Spalluto, G Pastorin
PHARMACOLOGY-RESEARCH, SAFETY TESTING AND REGULATION, 1-72, 2016
2016
系统目前无法执行此操作,请稍后再试。
文章 1–20